ArticleRSC advances2022

Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti-inflammatory agents.

Eman A Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.